China India experts pandemic Coronavirus China India

Diwali bonanza for Kotak PMS' Pharma & Healthcare investors, 43% returns in 1-yr

Reading now: 413
www.livemint.com

₹1.44 crore today (31st October, 2020). While the same invested in Nifty would have become about ₹1.32 crore and in Nifty Pharma about ₹96 lakh during the same period.

Kotak Mahindra Portfolio Management Service division (Kotak PMS), ahead of Diwali announced that it will share profits with investors generated from the Kotak Pharma and Healthcare (Kotak Pharma) portfolio.

Pharma and healthcare stocks have become market darlings. This has been driven by market expectations of a likely shift in global Pharma supply chains away from China and toward India.

Kotak Pharma and healthcare portfolio has been a direct beneficiary of this trend.Kotak Pharma & Healthcare portfolio has registered 13% returns over the past three years as compared to 4.8%.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA